Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...

CEO Silviu Itescu explains how Mesoblast changes a disease that is fatal 70% or 90% to a disease that can be cured.

Could you tell me about Premier? Mr. Alkire: Sure. Premier is a health care improvement company. We have two different segments to our business. We have a supply chain segment and a performance ...

Can you tell me about the company? Mr. Poirier: Sure. OSE Immunotherapeutics is a French biotech — the company is listed on Euronext Paris — and we are developing immunotherapies. Specifically, these ...

So let’s start with a brief history of the company and its mission. Mr. Pilcher: Sure. So Neuren is an interesting company, which has had a long history and a couple of incarnations. Twenty years ago ...

Could you tell us about the firm and your role there? Mr. Khuller: I’m the Vice President and Portfolio Manager at Letko Brosseau in Montreal, Canada. We manage about CAD18 billion in assets for our ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Ofer Gonen is CEO of MediWound Ltd. Prior to his CEO appointment in 2022, Mr. Gonen served as CEO of Clal Biotechnology Industries Ltd. (TASE:CBI), Israel’s leading life science investment ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.